Role of the angiotensin type 1 receptor in modulating the carotid chemoreflex in an ovine model of renovascular hypertension

被引:2
|
作者
Sohn, Chris Sung-Eun [1 ]
Chang, Joshua Wen-Han [1 ]
George, Bindu [1 ]
Chen, Siyi [1 ]
Ramchandra, Rohit [1 ]
机构
[1] Univ Auckland, Dept Physiol, Auckland, New Zealand
关键词
carotid body; chemoreflex; carotid blood flow; renal blood flow; hypertension; losartan; Ang-II; AT(1) receptor; SYMPATHETIC-NERVE ACTIVITY; II RECEPTOR; CONVERTING ENZYME; GENE-EXPRESSION; AT(1) RECEPTOR; HEART-FAILURE; BLOOD-FLOW; ONE-KIDNEY; BODY; 2-KIDNEY;
D O I
10.1097/HJH.0000000000003173
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: The carotid body has been implicated as an important mediator and putative target for hypertension. Previous studies have indicated an important role for angiotensin II in mediating carotid body function via angiotensin type-1 receptors (AT(1)R); however, their role in modulating carotid body function during hypertension is unclear. Methods: Using a large preclinical ovine model of renovascular hypertension, we hypothesized that acute AT(1)R blockade would lower blood pressure and decrease carotid body-mediated increases in arterial pressure. Adult ewes underwent either unilateral renal artery clipping or sham surgery. Two weeks later, flow probes were placed around the contralateral renal and common carotid arteries. Results: In both hypertensive and sham animals, carotid body stimulation using potassium cyanide caused dose-dependent increases in mean arterial pressure but a reduction in renal vascular conductance. These responses were not different between groups. Infusion of angiotensin II led to an increase in arterial pressure and reduction in renal blood flow. The sensitivity of the renal vasculature to angiotensin II was significantly attenuated in hypertension compared with the sham animals. Systemic inhibition of the AT(1)R did not alter blood pressure in either group. Interestingly carotid body-evoked arterial pressure responses were attenuated by AT(1)R blockade in renovascular hypertension but not in shams. Conclusion: Taken together, our findings indicate a decrease in vascular reactivity of the non-clipped kidney to angiotensin II in hypertension. The CB-evoked increase in blood pressure in hypertension is mediated in part, by the AT(1)R. These findings indicate a differential role of the AT(1)R in the carotid body versus the renal vasculature.
引用
收藏
页码:1421 / 1430
页数:10
相关论文
共 50 条
  • [41] Role of the angiotensin converting enzyme 1/angiotensin II/angiotensin receptor 1 axis in interstitial collagenase expression in human carotid atheroma
    Clancy, Paula
    Seto, Sai-Wang
    Koblar, Simon A.
    Golledge, Jonathan
    ATHEROSCLEROSIS, 2013, 229 (02) : 331 - 337
  • [42] Vascular angiotensin type 2 receptor contributes to the development of hypertension in SHR: Role of bradykinin
    Kamehara, Yuji
    Yayama, Katsutoshi
    Tanabe, Tohru
    Chin, Tokuchi
    Okamoto, Hiroshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 83P - 83P
  • [43] Angiotensin II type 2 receptor gene polymorphisms and cardioprotective role in essential hypertension
    Min Zhang
    Hong Ma
    Bo-song Wang
    Yong-zhong Zhao
    Heart and Vessels, 2006, 21 : 95 - 101
  • [44] Direct Angiotensin (ANG) II Type 2 Receptor (AT2R) Stimulation Inhibits Inflammation in Renovascular Hypertension (RVH)
    Matavelli, Luis C.
    Huang, Jiqian
    Siragy, Helmy M.
    HYPERTENSION, 2010, 56 (05) : E63 - E63
  • [45] Angiotensin II type 2 receptor gene polymorphisms and cardioprotective role in essential hypertension
    Zhang, M
    Ma, H
    Wang, BS
    Zhao, YZ
    HEART AND VESSELS, 2006, 21 (02) : 95 - 101
  • [46] Role of Mineralocorticoid and Angiotensin Type 1 Receptors in the Paraventricular Nucleus in Angiotensin-Induced Hypertension
    Burke, Sandra L.
    Barzel, Benjamin
    Jackson, Kristy L.
    Gueguen, Cindy
    Young, Morag J.
    Head, Geoffrey A.
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [47] Angiotensin II type I receptor blockade restores nitric oxide-dependent renal vascular responses in renovascular hypertension
    Martinez, Y
    Martinez, S
    Meaney, A
    Meaney, E
    Escalante, B
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2002, 40 (03) : 381 - 387
  • [48] Angiotensin II type 1 receptor blocker combined with hydrochlorothiazide for the treatment of hypertension
    Miura, Shin-ichiro
    Saku, Keijiro
    INTERNAL MEDICINE, 2008, 47 (13) : 1163 - 1164
  • [49] Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension
    Birkenhäger, WH
    de Leeuw, PW
    JOURNAL OF HYPERTENSION, 1999, 17 (07) : 873 - 881
  • [50] Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension
    Wang, WYS
    Zee, RYL
    Morris, BJ
    CLINICAL GENETICS, 1997, 51 (01) : 31 - 34